We are doing science for policy
The Joint Research Centre (JRC) is the European Commission's science and knowledge service which employs scientists to carry out research in order to provide independent scientific advice and support to EU policy.
Health is central to everybody’s life. It is also crucial for the wellbeing of society since only a healthy population stands to maximise its full economic and social potential.
Every citizen is keen to monitor their health. In case of sickness, patients take for granted that the diagnostic check-ups deliver the right results and subsequently trigger the correct treatment.
Correct diagnosis and the subsequent appropriate treatment rely on accurate and comparable measurements between laboratories and over time. Reference materials are essential in order to ensure such reliable and accurate results.
The JRC develops a wide range of Certified Reference Materials (CRMs) for a number of important health-status markers for diseases, such as cardiovascular diseases, leukaemia, tumours, kidney diseases, autoimmune diseases e.g. rheumatoid arthritis, and Alzheimer’s disease. In addition, the JRC supports the establishment of best-practice guidelines for clinical measurements.
Healthcare quality has a tremendous impact on the lives of citizens, their families and loved ones.
Collaboration between the Joint Research Centre and the European Commission Department for Health and Food Safety has led to the European Commission Initiative on Breast Cancer (ECIBC).
ECIBC translates the latest scientific evidence into personcentred quality requirements (guidelines) to improve the quality of the cancer healthcare pathway, i.e. from screening anddiagnosis to treatment, post-treatment and palliative care.
Those quality requirements are measurable, thus facilitating the monitoring, evaluation and improvement of all healthcare stages.
Combined with the fact that ECIBC is patient-centric, this initiative demonstrates how measuring the quality of care can improve cancer outcomes, including rates and trends in cancer survival.
Food allergy is recognised as a serious health problem and affects about 17 million people in Europe, 3.5 million of them younger than 25 years old.
The immune system of allergy sufferers reacts to the intake of some specific foods such as nuts, milk, eggs, and soya. Since there is no cure for allergies, allergic patients must strictly avoid the intake of allergens in their diet, meaning they rely on the correct labelling of allergenic ingredients in food products.
The JRC supports food control authorities with fit-for-purpose analytical methods for the detection of allergens, as well as with reference materials aimed at preventing an undesired intake of potentially harmful foodstuffs by allergic and food-intolerant consumers.